LKQ CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LKQ CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.65B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $13.82B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $13.27B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $12.79B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $13.09B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $11.63B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $12.51B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $11.88B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $9.74B | Feb 27, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $11.88B | Mar 1, 2019 |
| FY2017 | Dec 31, 2017 | $2.47B | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $2.47B | Feb 28, 2018 |
| FY2017 | Jun 30, 2017 | $2.46B | Feb 28, 2018 |
| FY2017 | Mar 31, 2017 | $2.34B | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $2.15B | Feb 28, 2018 |
| FY2017 | Sep 30, 2016 | $2.21B | Feb 28, 2018 |
| FY2017 | Jun 30, 2016 | $2.30B | Feb 28, 2018 |
| FY2017 | Mar 31, 2016 | $1.92B | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $1.75B | Feb 27, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.27B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $5.38B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $5.35B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $5.22B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $5.32B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $4.59B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $4.85B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $4.57B | Feb 26, 2021 |
| FY2017 | Dec 31, 2017 | $947.65M | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $956.88M | Feb 28, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $608.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $693.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $938.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.15B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.09B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $638.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $541.26M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $480.12M | Feb 26, 2021 |
| FY2017 | Dec 31, 2017 | $124.17M | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $122.38M | Feb 28, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $993.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.15B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.32B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.58B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.47B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $986.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $896.64M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $882.24M | Feb 26, 2021 |
| FY2017 | Dec 31, 2017 | $167.95M | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $199.10M | Feb 28, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.81B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $3.76B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $3.70B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $3.54B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $3.57B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $3.27B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $3.58B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $3.35B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $2.72B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $2.36B | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.06B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.12B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.36B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.25B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.37B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.44B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.06B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $710.74M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $518.90M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $635.01M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.14B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $14.96B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $15.08B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $12.04B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $12.61B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $12.36B | Feb 25, 2022 |
| FY2021 | Dec 31, 2019 | $12.78B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $11.39B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $9.37B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $8.30B | Mar 1, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.54B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.02B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $6.17B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $5.45B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $5.77B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $5.66B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $5.01B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $4.78B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.20B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.44B | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.41B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $5.17B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $5.33B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $4.32B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $4.54B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $4.59B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $4.41B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $4.38B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $3.54B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $3.05B | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.96B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $7.66B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $7.29B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $6.66B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $5.79B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $4.78B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $4.14B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $3.60B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $3.12B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.59B | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $319.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $234.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $299.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $278.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $274.00M | Feb 23, 2023 |
| FY2018 | Dec 31, 2018 | $331.76M | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | $279.77M | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | $227.40M | Mar 1, 2019 |
| FY2017 | Dec 31, 2015 | $87.40M | Feb 28, 2018 |
| FY2017 | Dec 31, 2014 | $114.61M | Feb 28, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Mar 1, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Mar 1, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 255.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 259.10M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 267.20M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | 267.30M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 287.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 303.55M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 306.73M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 316.15M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 309.13M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 307.54M | Feb 28, 2018 |